Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-030014

EVP, Drug Development sold 1,529 shares at $17.66 ($27,009)

  • EVP, Drug Development acquired 1,529 shares (other)

From the SEC's structured data for this filing

Trades in this filing

MANHARD KIMBERLY · EVP, Drug Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-30 Other acquisition : show line 1 in the form +1,529 $13.90 $21,249 3,163 D
2021-05-03 Sale : show line 2 in the form −1,529 $17.66 $27,009 1,634 D
Open-market sales · 1,529 sh · avg $17.66 · $27,009
Loading xslF345X03/doc4.xml…